Reardon William S
SEC-identified person · CIK 1212646 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Abrdn World Healthcare Fund THW | Director | filed 2015–2021 |
| Abrdn Healthcare Opportunities Fund THQ | Director | filed 2014–2021 |
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2006–2018 |
| Synta Pharmaceuticals Corp SNTA | Director | filed 2007–2015 |
| Abrdn Life Sciences Investors HQL | Director | filed 2010–2014 |
| Abrdn Healthcare Investors hqh | Director | filed 2010–2014 |
| Oscient Pharmaceuticals Corp OSCI | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.